Background. Drynariae Rhizoma (DR) has been widely used in the prevention and treatment of various fractures. However, the specific mechanisms of DR's active ingredients have not been elucidated. e purpose of this study was to explore the synergistic mechanisms of DR for treating fracture. Methods. A network pharmacology approach integrating ingredient screening, target exploration, active ingredients-gene target network construction, protein-protein interaction network construction, molecular docking, gene-protein classification, gene ontology (GO) functional analysis, KEGG pathway enrichment analysis, and signaling pathway integration was used. Results. is approach identified 17 active ingredients of DR, interacting with 144 common gene targets and 143 protein targets of DR and fracture. NCOA1, GSK3B, TTPA, and MAPK1 were identified as important gene targets. Five most important protein targets were also identified, including MAPK1, SRC, HRAS, RXRA, and NCOA1. Molecular docking found that DR has a good binding potential with common protein targets. GO functional analysis indicated that common genes involve multiple processes, parts and functions in biological process, cellular component, and molecular function, including positive regulation of transcription from RNA polymerase II promoter, signal transduction, cytosol, extracellular exosome, cytoplasm, and protein binding. e KEGG pathway enrichment analysis indicated that common gene targets play a role in repairing fractures in multiple signaling pathways, including MAPK, PI3K/AKT, Ras, and VEGF signaling pathways. MAPK and PI3K/AKT signaling pathways were involved in osteoblast formation, Ras signaling pathway was involved in enhancing mesenchymal stromal cell migration, and VEGF signaling pathway was involved in angiogenesis. Conclusion. e study revealed the correlation between DR and fracture and the potential synergistic mechanism of different targets of DR in the treatment of fractures, which provides a reference for the development of new drugs.
Introduction
Fracture is a common and frequent disease that occurs in patients with various injuries or osteoporosis [1] . In China, the population-weighted incidence of traumatic fractures of the legs, arms, or trunk in 2014 was 3.21 per 1,000 people (95% CI 2.83-3.59) [2] . Osteoporotic fractures are estimated to account for half of all fractures by 2050, and the estimated cost of osteoporotic hip fractures worldwide may reach $131 billion [3] . erefore, the study of drugs for the prevention and treatment of fractures plays an important role in promoting patient health and reducing family economic pressure.
Recently, DR, one of the plants from Davalliaceae and Davallia Sm., has been widely used in the prevention and treatment of various fractures due to excellent treatment,
Materials and Methods

Screening of Active Ingredients of Drynariae Rhizoma.
Traditional Chinese Medicine Systems Pharmacology (TCMSP, http://lsp.nwu.edu.cn/, Version 2.3) Database and Analysis Platform includes chemicals, targets, and drugtarget-disease networks, as well as pharmacokinetic properties involving oral bioavailability, druglikeness, bloodbrain-barrier, and so on [14] . ere were 71 compounds of DR which were obtained from the TCMSP. e potential active ingredients of DR for treating fracture were screened according to their oral bioavailability (OB) ≥30% and druglikeness (DL) ≥0.18 recommended by TCMSP.
Obtaining the Chemical Structure of Active Ingredients.
e structure of the potential active ingredients of DR was downloaded from TCMSP and stored in mol2 format. If there was no chemical structure, the PubChem compound was put into the PubChem (https://pubchem.ncbi.nlm.nih. gov/) to download a chemical structure and save it in sdf format, or the PubChem compound was put into the Zinc database (https://zinc.docking.org/) to download a chemical structure and save it in mol2 format. e related SMILES of potential active ingredients was received from TCMSP or PubChem or Zinc database. en, the SMILES was put into the Swiss Target Prediction database (http://www. swisstargetprediction.ch/) to obtain the related drug target and save it.
Gene Targets of Drynariae Rhizoma.
e DRAR-CPI server (http://cpi.bio-x.cn/drar, update in 2017-7-26) has a collection of drug molecules and targetable human proteins [15] . When submitting a drug molecule, the server docks the drug uploaded by users with the three-dimensional structure of all protein targets in the database, scores, and ranks them with the affinity scoring function based on the protein-ligand interaction, thereby predicting the potential protein targets of human-targetable drugs [15, 16] . is affinity score is called Z-score in the DRAR-CPI server [17] . Protein-ligand interaction with Z-score <− 0.5 was recommended by DRAR-CPI as a potential protein target for human-targetable drugs [16] . We uploaded the potential active ingredients of DR in mol2 or sdf format and used Z-score <− 0.5 to select potential protein targets for DR. A total of 1760 proteins with Z-score <− 0.5 and 355 protein targets were obtained after deletion of the duplicate data. e PDB ID of the protein targets were inputted into UniProt KB (http://www.uniprot. org/uniprot/) of the UniProt database, and the "popular organisms" was selected as human to obtain the gene targets associated with the potential active ingredient of DR.
Gene Target Prediction for Drynariae Rhizoma to Treat
Fractures. e following electronic databases were searched to identify the genes related to fractures: Genetic Association Database (https://geneticassociationdb.nih.gov/), erapeutic Targets Database (http://bidd.nus.edu.sg/BIDD-Databases/ TTD/TTD.asp), PharmGkb database (https://www. pharmgkb.org/), GeneCards database (http://www.genecards. org/), and OMIM database (http://www.ncbi.nlm.nih.gov/ omim). en, the duplicate data and false-positive genes were deleted. Finally, the Venny tool (http://bioinfogp.cnb.csic. es/tools/venny/index.html, Version 2.1) was used to identify the common gene targets of DR and fracture, which may be the potential targets for DR to treat fractures.
Constructing the Ingredient-Target Network of Drynariae
Rhizoma.
e common gene targets of DR and fracture were introduced into the Cytoscape software (Version 3.4.0) to construct an ingredient-target network of Drynariae Rhizoma and analyze the topology properties of the network, including degree, betweenness centrality, and closeness centrality [18] . e degree describes the number of connections to a node in the network, indicating interaction with other nodes in the network. Betweenness centrality measures the proportion of a node between shortest paths among other nodes, suggesting the importance of nodes in maintaining network tightness. Closeness centrality indicates the degree of nodes close to the "center" of the network. A node with high degree, betweenness centrality, and closeness centrality values means that it plays a very important role in the network [18] .
Constructing Protein-Protein Interaction (PPI) of Drynariae Rhizoma.
e String database (https://string-db.org/, Version 10.5) is a database containing known and predicted PPIs, which collect and integrate a large number of protein interactions involving 9,643,763 proteins and 1,380,838,440 interactions, including experimental data and interactive prediction data derived from bioinformatic methods [19] . Common gene targets of DR and fracture were imported into the STRING database, and the species were set to humans for PPIs. en, the highest confidence was set to 0.9 in the minimum required interaction score and the results were updated. e TSV format of the updated results were downloaded. en, node1, node2, and combined scores were extracted and imported into the Cytoscape software to create a PPI network, and the network was analyzed as follows:
Step 1: analyze the topology properties of the network: cytoscape ⟶ tools ⟶ network analyzer ⟶ network analysis ⟶ analyze network, save the CSV format of the network result and extract the degree value.
Step 2: create a network map according to the degree: cytoscape ⟶ tool ⟶ network analyzer ⟶ network analysis ⟶ generate style from statistics ⟶ map node size to degree ⟶ map node color to degree and save the PPI network map.
Molecular
Docking. SystemsDock (http://systemsdock. unit.oist.jp, Version 2.0) is a web server for network pharmacology-based prediction and analysis that could be used to illustrate the role of ligands on a complex molecular network [20] . It evaluates the protein-ligand binding potential of molecular docking by combining docking with the intelligence (dock-IN) score. e dock-IN score is the negative logarithm of the experimental dissociation/inhibition constant (pKd/pKi), which ranges from 0 to 10, indicating weak to strong binding [20] . It is believed that the docK-IN score above 4.25 indicates a slight binding potential between the protein and ligand; a value greater than 5.0 indicates a moderate binding potential, and a value greater than 7.0 indicates a strong binding potential [16] . We extracted the top 5 proteins with the highest degree value in the PPI network. e proteins that were recognized by systemsDock docked with the potential active ingredients of DR to receive the dock-IN score. e results were saved, and their dock-IN score was analyzed to assess the binding potentials between the potential active ingredients of DR and protein targets.
GO Functional Analysis and KEGG Pathway Enrichment
Analysis. GO (http://www.geneontology.org) is widely used for annotation of gene function, providing detailed annotations of gene function in terms of biological process (BP), cellular component (CC), and molecular function (MF), respectively [21] . Database for annotation, visualization, and integrated discovery (David, https://david.ncifcrf.gov/, Version 6.8) is a functional genomic annotation database that provides bioinformatics annotation for genes or proteins based on the gene annotation function of the GO database and the signaling pathway information of the KEGG database [22] . We performed GO functional analysis and KEGG pathway enrichment analysis in the David database.
e procedure was as follows:
Step 1: paste the common gene targets of DR and fracture list. Step 2: select "OFFICIAL_GENE_SYMBOL" in "Select Identifier." Step 3: select "Gene List" in "List Type." Step 4: select "Homo sapiens" in species.
Step 5: submit list.
Step 6: download the results of BP, CC, and MF in the gene ontology.
Step 7: download the results of KEGG pathway in the pathways.
Step 8: targets with P < 0.05 were screened and sorted by count (number of targets), and the top-ranked biological processes or KEGG pathways were extracted. Step 9: BP, CC, and MF were designed using GraphPad Prism 5.0 software. e KEGG pathways were designed by the advanced bubble chart of the omicshare tool (http://omicshare.com/tools/ Home/Soft/getsoft/type/index).
Collect Protein Class Corresponding to Common Gene Targets. DisGeNET
(http://www.disgenet.org/web/ DisGeNET/menu, Version 5.0) is a discovery platform that contains one of the largest publicly available genes and variants associated with human disease. It could be used to analyze the properties of disease genes and investigate the molecular basis of specific diseases and their comorbidities, as well as adverse drug reactions [23] . We used the search function of the DisGeNET platform to retrieve the protein class corresponding to common gene targets.
Pathway Integration.
We used the KEGG Mapper tool in the KEGG database (http://www.kegg.jp/) to retrieve some pathways of DR for fractures and then integrate into a final pathway map. e procedure was as follows:
Step 1: used the UniProt KB search function of the UniProt database to retrieve the UniprotID of the common gene targets.
Step 2: import the UniProt ID of the common gene targets.
Step 3: set the parameters: search against: hsa, primary ID: NCBI-UniProt ID, and examples: Homo sapiens pathway.
Step 4: download the PI3K-AKT, MAPK, Ras, and VEGF signaling pathways.
Step 5: integrate the signal path.
Results
Active Ingredients of Drynariae Rhizoma.
A total of 71 ingredients of DR were retrieved from TCMSP, and 18 active ingredients were screened according to the biological functions of DR. However, marioside_qt (Molecule ID: MOL009087) was removed because it could not be recognized by the PubChem or Zinc database. e remaining 17 active ingredients are shown in Table 1 , including (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one, aureusidin, eriodictyol (flavanone), stigmasterol, beta- 
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Gene Target Prediction.
A total of 303 gene targets associated with the potential active ingredients of DR were retrieved in the UniProt database. A total of 3,173 fracturerelated genes were received, and 3,054 genes remained after deletion of the duplicate and false-positive genes. Common gene target screening for fracture and DR are shown in Figure 1 . A total of 144 common gene targets of DR and fracture were received, indicating the potential targets for DR to treat fractures, as shown in Table 2 . Gene target  1  1HSZ  ADH1B  2  1HT0  ADH1C  3  1D1T  ADH7  4  1H0C  AGXT  5  3CQW  AKT1  6  1O6L  AKT2  7  2GLQ  ALPP  8  1ANG  ANG  9  1HAK  ANXA5  10  1E3G  AR  11  2NZ2  ASS1  12  1ONQ  B2M  13  1XLV  BCHE  14  1ES7  BMP2  15  1M4U  BMP7  16  1ES7  BMPR1A  17  1UWJ  BRAF  18  1A42  CA2  19  1ICE  CASP1  20  1K86  CASP7  21  2C2Z  CASP8  22  2HRB  CBR3  23  1JBQ  CBS  24  1ONQ  CD1A  25  1POZ  CD44  26  2OBD  CETP  27  1XMI  CFTR  28  3DRB  CKB  29  1NN6  CMA1  30  3BWY  COMT  31  1NM8  CRAT  32  1C8P  CSF2RB  33  1BYG  CSK  34  1CSB  CTSB  35  1LYW  CTSD  36  1CGH  CTSG  37  1JKL  DAPK1  38  2HHA  DPP4  39  1M17  EGFR  40  1H1B  ELANE  41  1R5K  ESR1  42  1QKM  ESR2  43  2PJL  ESRRA  44  1F0R  F10  45  1A3B  F2  46  1Z6J  F3  47  1Z6J  F7  48  1RFN  F9  49  2FGI  FGFR1  50  2PVY  FGFR2  51  2BH9  G6PD  52  1ZNQ  GAPDH  53  1OGS  GBA  54  1J78  GC  55  1PUB  GM2A  56  1J1B  GSK3B  57  1GRE  GSR  58  1XWK  GSTM1  59 11GS GSTP1 Gene target  60  2C3Q  GSTT1  61  2VQM  HDAC4  62  1GMN  HGF  63  1HWL  HMGCR  64  1S8C  HMOX1  65  5P21  HRAS  66  1DHT  HSD17B1  67  1ZBQ  HSD17B4  68  1YET  HSP90AA1  69  2OJ9  IGF1R  70  1ZT3  IGFBP1  71  2ILK  IL10  72  1G0Y  IL1R1  73  2CYK  IL4  74  1TYL  INS  75  2AUH  INSR  76  1QCY  ITGA1  77  2B7A  JAK2  78  1ZSX  KCNAB2  79  1QPC  LCK  80  1I0Z  LDHB  81  1KJL  LGALS3  82  1TVO  MAPK1  83  1JNK  MAPK10  84  1A9U  MAPK14  85  1UKI  MAPK8  86  2DFD  MDH2  87  1GCZ  MIF  88  1DMT  MME  89  1HFC  MMP1  90  1QIA  MMP3  91  1JAP  MMP8  92  1SD2  MTAP  93  2P54  NCOA1  94  1MVC  NCOA2  95  2IIP  NNMT  96  1M4U  NOG  97  1NSI  NOS2  98  1KBQ  NQO1  99  1UPV  NR1H2  100  3FXV  NR1H4  101  1NRL  NR1I2  102  1P93  NR3C1  103  2A3I  NR3C2  104  1YOW  NR5A1  105  1WWA  NTRK1  106  1WWB  NTRK2  107  1OTH  OTC  108  1WOK  PARP1  109  2QYK  PDE4A  110  1PTW  PDE4D  111  1ZUC  PGR  112  2VGB  PKLR  113  1VJA  PLAU  114  2PK4  PLG  115  1NRG  PNPO  116  1V04  PON1  117  1B1C  POR  118  2P54  PPARA  119 2J14 PPARD Evidence-Based Complementary and Alternative Medicine
No. PDB ID
Ingredient-Target Network of Drynariae Rhizoma.
e active ingredients and gene targets of DR was inputted into Cytoscape software to construct the ingredient-target network, as shown in Figure 2 . In the network, the pink oval nodes represent the main active ingredients of DR, and the light green rectangle nodes represent the potential gene targets for DR to treat fractures. e line represents the correlation between the active ingredients of DR and the gene targets.
ere are 161 nodes and 774 lines in the network. An active ingredient could be linked to different gene targets, and a gene target could be linked to different active ingredients, suggesting the multicomponent and multitarget characteristics of DR. e topology properties of active ingredients of DR are shown in Supplementary Table 1. Both cyclolaudenol and cycloartenone were linked to a maximum number of gene targets, with 70 (48.61%) different gene targets. Cyclolaudenol acetate was linked to 54 (37.5%) different gene targets. Xanthogalenol was linked to a minimum number of gene targets for a total of 29 (20.14%). In addition, there were four gene targets with the top four degree values, betweenness centrality, and closeness centrality at the same time (Table 3) , which were NCOA1, GSK3B, TTPA, and MAPK1.
Protein-Protein Interaction of Drynariae Rhizoma.
e PPI network of DR is shown in Figure 3 . In the network, the node represents the protein, and the size and color of the node represent the value of the degree. e larger the node and the brighter the color (yellow to blue), the greater the value of the degree. e line indicates the association between proteins. Results showed that there were 143 nodes and 315 lines.
Degree in the network indicates the number of proteins that a protein has interacting with. In other words, topdegree protein targets screened in PPI plays a pivotal role in the treatment of fractures with DR. Five important protein targets with top degree of DR were identified in the PPI network and are shown in Table 4 . ey were MAPK1, SRC, HRAS, RXRA, and NCOA1.
Molecular Docking.
ree important protein targets with top degree of DR were identified by SystemsDock, including SRC, RXRA, and NCOA1. Dock-IN score of these three proteins docked with 17 active ingredients of DR are shown in Table 5 . Molecular docking results showed that there were 17 (33.33%) with a dock-IN score greater than 7.0, 24 (47.06%) with a dock-IN score between 7.0 and 5.0, 8 (15.69%) with a dock-IN score between 5.0 and 4.25, and 2 (3.92%) with a dock-IN score less than 4.25.
Gene Ontology (GO) Functional Analysis and KEGG
Pathway Enrichment Analysis. Enriched gene ontology terms for BP, CC, and MF of potential therapeutic fracture targets from the main active ingredients of DR are shown in Figure 4 . In the BP (Figure 4(a) ), positive regulation of transcription from RNA polymerase II promoter involved 33 (22.92%) potential therapeutic fracture targets, signal transduction involved 30 (20.84%) potential therapeutic fracture targets, negative regulation of transcription from RNA polymerase II promoter involved 20 (13.89%) potential therapeutic fracture targets, positive regulation of transcription and DNA-template involved 19 (13.19%) potential therapeutic fracture targets, and transcription initiation from RNA polymerase II promoter involved 18 (12.5%) potential therapeutic fracture targets. In the CC (Figure 4(b) ), cytosol involved 63 (43.75%) potential therapeutic fracture targets, extracellular exosome involved 60 (41.67%) potential therapeutic fracture targets, cytoplasm involved 58 (40.28%) potential therapeutic fracture targets, nucleus involved 56 (38.89%) potential therapeutic fracture targets, and plasma membrane involved 53 (36.81%) potential therapeutic fracture targets. In the MF (Figure 4(c) ), protein binding involved 110 (76.39%) potential therapeutic fracture targets, zinc ion binding involved 31 (21.53%) potential therapeutic fracture targets, identical protein binding involved 29 (20.14%) potential therapeutic fracture targets, ATP binding involved 27 (18.75%) potential therapeutic fracture targets, and enzyme binding involved 23 (15.97%) potential therapeutic fracture targets.
Enriched KEGG pathways of potential targets for treating fracture from the main active ingredients of DR are shown in Figure 5 . e MAPK signaling pathway was identified as an important signaling pathway involving 17 (11.81%) potential therapeutic fracture targets with P � 7.82 × 10 − 6 . e PI3K-Akt signaling pathway involved 17 (11.81%) potential therapeutic fracture targets, the Rap1 signaling pathway involved 14 (9.72%) potential therapeutic fracture targets, the Ras signaling pathway Gene target  120  1ZEO  PPARG  121  1CYN  PPIB  122  1QMV  PRDX2  123  2GU8  PRKACA  124  1LQV  PROCR  125  1HDR  QDPR  126  1QAB  RBP4  127  2G1N  REN  128  1MVC  RXRA  129  1OLM  SEC14L2  130  1F5F  SHBG  131  1I92  SLC9A3R1  132  2C9V  SOD1  133  1YOL  SRC  134  1P49  STS  135  1J99  SULT2A1  136  1NAV  THRA  137  1NAX  THRB  138  1A8M  TNF  139  1HTI  TPI1  140  1D0A  TRAF2  141  1OIZ  TTPA  142  1QAB  TTR  143  1UOU  TYMP  144  3CS4  VDR   8 Evidence-Based Complementary and Alternative Medicine involved 14 (9.72%) potential therapeutic fracture targets, and the signaling pathways regulating pluripotency of stem cells involved 12 (9.03%) potential therapeutic fracture targets.
Protein Class Corresponding to Common Gene
Targets. e protein class corresponding to potential targets for treating fracture from the main active ingredients of DR is presented in Table 6 . e results showed that DR treatment 
Signaling Pathway Integration.
Four pathways associated with the potential targets of DR main active ingredients for treating fracture are presented in Figure 6 . e arrow (⟶) indicates the promoting effect, the T-arrows (⊣) indicate the inhibition, and the arrows of different colors represent different signaling pathways. e targets of the signaling pathway were marked as light blue, and the potential targets of DR main active ingredients for treating fracture were marked as dark blue. ere were 21 (14.58%) potential targets of main active ingredients of DR for treating fracture in the PI3K-AKT, MAPK, Ras, and VEGF signaling pathways, indicating that the fracture targets play a role in these signaling pathways. In addition, some targets play a role in a variety of signaling pathways, such as Ras, RafB, AKT/PKB, PI3K, ERK, and JNK.
Discussion
In order to reveal the relationship between fracture and the active ingredients involved in the DR, we predicted the mechanism of DR treatment fractures by constructing a biological network of interactions between active ingredients and common gene targets and common protein targets from a molecular level. A total of 17 active ingredients of DR were received in our study, including (2R)-5,7-dihydroxy-2-(4- [24] . In addition, Kang Suk-Nam finds that the total phenolics and flavonoids of DR are better Evidence-Based Complementary and Alternative Medicine extracted with 70% ethanol instead of water, and this ethanol extraction method also makes these extracts have higher antioxidant activity and in vitro antiosteoporosis effect [25] .
In the ingredient-target network, all active ingredients were also identified to bind well to the fracture gene targets, binding to at least 29 (20.14%) different gene targets. erefore, the 17 active ingredients of DR may have the effect of reducing bone loss and promoting fracture healing.
In our study, 144 common gene targets of DR and fracture were received, and 774 interactions between the active ingredients of DR and common gene targets were found. Some gene targets have been confirmed by clinical trials or animal experiments. For example, Guimarães et al. found that polymorphisms in the FGFR1 and BMP4 genes were associated with fracture nonunion in patients [26] . And our team's previous study also found that the total flavonoids of DP could promote osteogenesis and mineralization in rats with tibial defects by increasing the gene expression of BMP2, BMP4, BMPR1A, and Smadl [27] . In the ingredient-target network, NCOA1, GSK3B, TTPA, and MAPK1 were identified as important gene targets based on degree values, betweenness centrality, and closeness centrality. Qin et al. found [31] . ese gene targets are involved in vascularization, osteoblast differentiation, and osteoclastogenesis in fracture repair. Besides, we found that one active ingredient can interact with different gene targets, and one gene target can interact with different active ingredients, which is consistent with the modern drug theory of "multi-ingredient, multitarget" [9] .
To identify the interactions of proteins corresponding to common genes, we conducted a PPI network. A total of 143 common protein targets for DR and fracture were received, with 315 PPIs. In addition, MAPK1, SRC, HRAS, RXRA, and NCOA1 were identified as the five most important target proteins. Previous studies have found that MAPK1 and SRC could promote proliferation and differentiation of myeloid cells and inhibit apoptosis [32, 33] . Clinical cases have found that elevated levels of fibroblast growth factor 23 in patients with dysplasia are associated with HRAS mutations [34] . RXRA is an essential cofactor in the action of 1,25-dihydroxyvitamin D, and umbilical cord RXRA methylation was inversely related to offspring bone mineral content [35] . Coronnello et al. found that NCOA1 modulate the estrogen effects in bone, and miR-488-5p overexpression reduces NCOA1 protein levels, thereby reducing bone mineral density [36] . ese protein targets are associated with bone growth and angiogenesis in fracture repair. At the same time, we docked SRC, RXRA, and NCOA1 with 17 potential active ingredients of DR and found that 41 (80.39%) had moderate binding potential, suggesting that DR could bind well to fracture-related protein targets. In order to identify the function of the common gene, we performed GO functional analysis on these genes. e results showed that the common gene involves multiple processes, parts and functions in BP, CC, and MF, which was consistent with existing studies about DR and fracture repair. For example, in the BP, 33 (22.92%) gene targets were involved in positive regulation of transcription from the RNA polymerase II promoter, and 30 (20.84%) gene targets were involved in signal transduction. Previous studies have shown that the promoter activates the polymerase to bind precisely to the template DNA and has the specificity of transcription initiation [37] . e RNA polymerase II promoter responsible for mRNA transcription is the largest and most important class of promoters [37] . is provides conditions for DR to initiate osteogenic targets. Besides, some signal transduction genes have been found in experiments. Song Nan found that VEGFR-2 may play a signal transduction role for naringin, one ingredient of DR, to stimulate angiogenesis and promote fracture healing [38] . In the CC, 63 (43.75%) gene targets were involved in cytosol, 60 (41.67%) gene targets were involved in extracellular exosome, and 58 (40.28%) gene targets were involved in cytoplasm.
is indicates that the recovery of the fracture requires the support of various components in the cell, which is consistent with previous studies [39] . In the MF, 110 (76.39%) gene targets were involved in protein binding, suggesting that mutual recognition between proteins has good gene regulation conditions. is is consistent with the protein class corresponding to the potential target. ese results were further validated in the protein class corresponding to the common gene. In the protein class, all of these common genes have been found to regulate a variety of fracture-related molecules, such as transcription factors, receptors, enzyme regulators, molecular chaperones, cell adhesion molecules, enzyme, and so on.
In order to identify the synergistic mechanism of DR for fracture, we performed KEGG pathway enrichment analysis and summarized some important signaling pathways, which provides direction for future research. In the KEGG pathway enrichment analysis, 17 (11.81%) gene targets were involved in MAPK signaling pathway, 17 (11.81%) gene targets were involved in PI3K-Akt signaling pathway, 14 (9.72%) gene targets were involved in Ras signaling pathway, and 6 (4.17%) gene targets were involved in VEGF signaling pathway, which suggest that common gene targets play a role in repairing fractures in multiple signaling pathways. MAPK and PI3K/AKT signaling pathways have been demonstrated to promote osteoblastic bone formation [40] . Zhang et al. confirmed that total flavonoids from DR promote the osteogentic differentiation of ciliary neurotrophic factormodified myoblasts by activating p38 MAPK signaling pathway [41] . Moreover, total flavonoids of DR could promote osteogenic differentiation of rat dental pulp stem cells via the PI3K/Akt pathway [42] . Lin et al. found that the effect of naringin on the healing of fracture may be related to the promotion of the synthesis and secretion of cellular chemokines (CXCL5, CXCL6) and enhancement of mesenchymal stromal cell migration through Ras signaling pathway [43] . In addition, naringin stimulates angiogenesis by regulating the VEGF/VEGFR-2 signaling pathway in rats, thereby promoting fracture healing [38] . However, the mechanism of some active ingredients of DR in the treatment of fractures has not yet been verified. erefore, we integrated MAPK, PI3K/AKT, Ras, and VEGF signaling pathways to provide a reference for researchers to verify the mechanism of other DR active ingredients in the treatment of fractures.
Conclusion
We collected the gene and protein targets of fractures and active ingredients of DR and then used network pharmacology to reveal the correlation between drugs and diseases and the potential synergistic mechanism of different targets of DR in the treatment of fractures, which provides a reference for the development of new drugs.
